High ambient glucose enhances sensitivity to TGF-β1 via extracellular signal-regulated kinase and protein kinase Cδ activities in human mesangial cells

Journal of the American Society of Nephrology

Volumn 15, Issue 8, 2004, Pages 2032-2041

  Hayashida, Tomoko ^a   Schnaper, H William ^b  

^a Pediatrics W 140   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CEFALOTIN; COLLAGEN; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PROTEIN KINASE C DELTA; ROTTLERIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING;

EID: 3543150126     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000133198.74973.60     Document Type: Article

References (50)

1. Remuzzi O, Ruggenenti P: Prognosis of diabetic nephropathy: How to improve the outcome. Diabetes Res Clin Pract 39[Suppl]: S49-S53, 1998
2. Mauer SM, Steffes MW, Brown DM: The kidney in diabetes. Am J Med 70: 603-612, 1981
3. Holleman F, Hoekstra JB: Insulin lispro. N Engl J Med 337: 176-183, 1997
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
5. Reusch JE: Diabetes, micro vascular complications, and cardiovascular complications: What is it about glucose? J Clin Invest 112: 986-988, 2003
6. Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373, 2003
7. Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 44: 929-935, 1995
8. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22: 736-744, 1993
9. Yamamoto T, Noble N, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45: 916-927, 1994
10. Sharma K, McGowan TA: TGF-β in diabetic kidney disease: Role of novel signaling pathways. Cytokine Growth Factor Rev 11: 115-123, 2000
11. Akai Y, Sato H, Ozaki H, Iwano M, Dohi Y, Kanauchi M: Association of transforming growth factor-β1 T29C polymorphism with the progression of diabetic nephropathy. Am J Kidney Dis 38: S182-S185, 2001
12. Wahab NA, Harper K, Mason RM: Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J 316: 985-992, 1996
13. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN: Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration. Kidney Int 54: 1107-1116, 1998
14. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
15. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 91: 8015-8020, 2000
16. Chen S, Carmen Iglesias-de la Cruz M, Jim B, Hong SW, Isono M, Ziyadeh FN: Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice. Biochem Biophys Res Commun 300: 16-22, 2003
17. Schiffer M, von Gersdorff G, Bitzer M, Susztak K, Bottinger EP: Smad proteins and transforming growth factor-β signaling. Kidney Int Suppl 77: S45-S52, 2000
18. Massague J, Chen YG: Controlling TGF-β signaling. Genes Dev 14: 627-644, 2000
19. de Caestecker MP, Peik E, Roberts AB: Role of transforming growth factor-β signaling in cancer. J Natl Cancer Inst 92: 1388-1402, 2000
20. Hayashida T, Poncelet AC, Susan CH, Schnaper HW: TGF-β1 activates MAP kinase pathways in human mesangial cells, a possible role for collagen expression. Kidney Int 56: 1710-1720, 1999
21. Hayashida T, DeCaestecker M, Schnaper HW: Cross-talk between ERK MAP kinase and Smad-signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 17: 1576-1578, 2003
22. Runyan CE, Schnaper HW, Poncelet AC: Smad3 and PKCδ mediate TGF-β1-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol 285: F413-F422, 2003
23. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261: F571-F577, 1991
24. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial Superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000
25. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, Shearman CW: Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV in mesangial cells. Am J Physiol 276: F684-F690, 1999
26. Cohen MP, Shea E, Shearman CW: ERK mediates effects of glycated albumin in mesangial cells. Biochem Biophys Res Commun 283: 641-643, 2001
27. Awazu M, Ishikura K, Hida M, Hoshiya M: Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J Am Soc Nephrol 10: 738-745, 1999
28. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853, 1997
29. Tomlinson DR: Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42: 1271-1281, 1999
30. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin invest 100: 115-126, 1997
31. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000
32. Whiteside CI, Dlugosz JA: Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol 282: F975-F980, 2002
33. Poncelet AC, Schnaper HW: The transforming growth factor β/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56: 1354-1365, 1999
34. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massague J: TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992
35. Hubchak SC, Runyan CE, Kreisberg JI, Schnaper HW: Cytoskeletal rearrangement and signal transduction in TGF-β1-stimulated mesangial cell collagen accumulation. J Am Soc Nephrol 14: 1969-1980, 2003
36. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284, 1994
37. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney Int 54: 1872-1878, 1998
38. Isono M, Mogyorosi A, Han DC, Hoffman BB, Ziyadeh FN: Stimulation of TGF-β type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am J Physiol Renal Physiol 278: F830-F838, 2000
39. Riser BL, Ladson-Wofford S, Sharba A, Cortes P, Drake K, Guerin CJ, Yee J, Choi ME, Segarini PR, Narins RG: TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain. Kidney Int 56: 428-439, 1999
40. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C: Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197, 1993
41. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F: Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98, 1994
42. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC: TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284: F243-F252, 2003
43. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN: Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158: 1653-1663, 2001
44. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN: Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 296: 1356-1365, 2002
45. Li JH, Huang XR, Zhu HJ, Johnson R, Lan HY: Role of TGF-β signaling in extracellular matrix production under high glucose conditions. Kidney Int 63: 2010-2019, 2003
46. Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S: Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 305: 1002-1007, 2003
47. Hua H, Goldberg HJ, Fantus IG, Whiteside CI: High glucose-enhanced mesangial cell extracellular signal-regulated protein kinase activation and α1(IV) collagen expression in response to endothelin-1: Role of specific protein kinase C isozymes. Diabetes 50: 2376-2383, 2001
48. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN: Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11: 2222-2230, 2000
49. Biggs JR, Kraft AS: The role of the Smad3 protein in phorbol ester-induced promoter expression. J Biol Chem 274: 36987-36994, 1999
50. Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J: Transforming growth factor-β stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase Co, and p38. Am J Respir Cell Mol Biol 26: 183-188, 2002